Findings of Research Misconduct, 31052 [2015-13054]
Download as PDF
<![CDATA[
31052
Federal Register / Vol. 80, No. 104 / Monday, June 1, 2015 / Notices
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this Information
Collection Request are summarized in
the table below.
Number of
respondents
Form name
Number of
responses per
respondent
Total Estimated Annualized burden
hours:
Total
responses
Average
urden per
response
in hours)
Total burden
hours
Rural Outreach Benefits Counseling Grant Program Measures ...................................................................................
10
1
10
1.5
15
Total ..............................................................................
10
1
10
1.5
15
HRSA specifically requests comments
on: (1) The necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions; (2) the accuracy of the
estimated burden; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Jackie Painter,
Director, Division of the Executive Secretariat.
[FR Doc. 2015–13088 Filed 5–29–15; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
Office of the Secretary, HHS.
ACTION: Notice.
AGENCY:
Notice is hereby given that
the Office of Research Integrity (ORI)
has taken final action in the following
case:
Ryan Asherin, Oregon Health
Authority: Based on the report of an
investigation conducted by the Oregon
Health Authority (OHA) and analysis
conducted by ORI in its oversight
review, ORI found that Ryan Asherin,
former Surveillance Officer and
Principal Investigator, OHA, Public
Health Division engaged in research
misconduct in research supported by
the Centers for Disease Control and
Prevention (CDC) Emerging Infections
Program Grant 5U01CI00306–05.
ORI found that the Respondent
engaged in research misconduct by
falsifying and/or fabricating data that
were included in the CDC research
record, a manuscript submitted to JAMA
Intern Med in January 2013, a published
CDC report (CDC Morbidity and
Mortality Weekly Report 61(09):157–
162, March 2012), and presentations in
Lhorne on DSK2VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
14:50 May 29, 2015
Jkt 235001
2012 to CDC and at the 11th Biennial
Congress of the Anaerobe Society.
ORI found that the Respondent
falsified and/or fabricated fifty-six (56)
case report forms (CRFs) while
acquiring data on the incidence of
Clostridium difficile infections in
Klamath County, Oregon. Specifically,
the Respondent (1) fabricated responses
to multiple questions on the CRFs for
patient demographic data, patient health
information, and Clostridium difficile
infection data, including the diagnoses
of toxic megacolon and ileus and the
performance of a colectomy, with no
evidence in patient medical records to
support the responses; and (2) falsified
the CRFs by omitting data on the CRFs
that clearly were included in patient
medical records.
Mr. Asherin has entered into a
Voluntary Settlement Agreement
(Agreement) and has voluntarily agreed
for a period of two (2) years, beginning
on May 12, 2015:
including, but not limited to, service on any
PHS advisory committee, board, and/or peer
review committee, or as a consultant.
(1) To have his research supervised;
Respondent agrees that prior to submission of
an application for U.S. Public Health Service
(PHS) support for a research project on which
the Respondent’s participation is proposed
and prior to Respondent’s participation in
any capacity on PHS-supported research,
Respondent shall ensure that a plan for
supervision of Respondent’s duties is
submitted to ORI for approval; the
supervision plan must be designed to ensure
the scientific integrity of Respondent’s
research contribution; Respondent agrees that
he will not participate in any PHS-supported
research until such a supervision plan is
submitted to and approved by ORI;
Respondent agrees to maintain responsibility
for compliance with the agreed upon
supervision plan;
(2) that any institution employing him
must submit, in conjunction with each
application for PHS funds, or report,
manuscript, or abstract involving PHSsupported research in which Respondent is
involved, a certification to ORI that the data
provided by Respondent are based on actual
experiments or are otherwise legitimately
derived and that the data, procedures, and
methodology are accurately reported in the
application, report, manuscript, or abstract;
and
(3) to exclude himself voluntarily from
serving in any advisory capacity to PHS
SUMMARY:
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
FOR FURTHER INFORMATION CONTACT:
Acting Director, Office of Research
Integrity, 1101 Wootton Parkway, Suite
750, Rockville, MD 20852, (240) 453–
8200.
Donald Wright,
Acting Director, Office of Research Integrity.
[FR Doc. 2015–13054 Filed 5–29–15; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the 2015 Hurricane Sandy
Conference: Translating Research Into
Practice
Department of Health and
Human Services, Office of the Secretary.
ACTION: Notice.
AGENCY:
The Department of Health and
Human Services (HHS) Office of the
Assistant Secretary for Preparedness
and Response (ASPR) is hereby giving
notice that ASPR will convene a
Hurricane Sandy Conference:
Translating Research into Practice
public meeting on August 10–11, 2015.
The purpose of the meeting is to broadly
share, with interested stakeholders,
outcomes of Hurricane Sandy recovery
science research and training projects
awarded under ASPR FOAs EP–HIT–
13–001 and EP–HIT–14–001, Centers for
Disease Control and Prevention (CDC)
FOAs TP13–001 and OH13–002, and
National Institute of Environmental
Health Sciences (NIEHS) FOAs RFA–
ES–13–008 and NOT–ES–13–003.
Meeting participants will discuss
opportunities to build a community of
practice around Hurricane Sandy
recovery research and the path forward
for translating Hurricane Sandy
recovery science research results into
practice; highlight Hurricane Sandy
recovery science grants as a model for
disaster research science preparedness;
and demonstrate the benefit of
E:\FR\FM\01JNN1.SGM
01JNN1
]]>Agencies
[Federal Register Volume 80, Number 104 (Monday, June 1, 2015)]
[Notices]
[Page 31052]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-13054]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the Office of Research Integrity
(ORI) has taken final action in the following case:
Ryan Asherin, Oregon Health Authority: Based on the report of an
investigation conducted by the Oregon Health Authority (OHA) and
analysis conducted by ORI in its oversight review, ORI found that Ryan
Asherin, former Surveillance Officer and Principal Investigator, OHA,
Public Health Division engaged in research misconduct in research
supported by the Centers for Disease Control and Prevention (CDC)
Emerging Infections Program Grant 5U01CI00306-05.
ORI found that the Respondent engaged in research misconduct by
falsifying and/or fabricating data that were included in the CDC
research record, a manuscript submitted to JAMA Intern Med in January
2013, a published CDC report (CDC Morbidity and Mortality Weekly Report
61(09):157-162, March 2012), and presentations in 2012 to CDC and at
the 11th Biennial Congress of the Anaerobe Society.
ORI found that the Respondent falsified and/or fabricated fifty-six
(56) case report forms (CRFs) while acquiring data on the incidence of
Clostridium difficile infections in Klamath County, Oregon.
Specifically, the Respondent (1) fabricated responses to multiple
questions on the CRFs for patient demographic data, patient health
information, and Clostridium difficile infection data, including the
diagnoses of toxic megacolon and ileus and the performance of a
colectomy, with no evidence in patient medical records to support the
responses; and (2) falsified the CRFs by omitting data on the CRFs that
clearly were included in patient medical records.
Mr. Asherin has entered into a Voluntary Settlement Agreement
(Agreement) and has voluntarily agreed for a period of two (2) years,
beginning on May 12, 2015:
(1) To have his research supervised; Respondent agrees that
prior to submission of an application for U.S. Public Health Service
(PHS) support for a research project on which the Respondent's
participation is proposed and prior to Respondent's participation in
any capacity on PHS-supported research, Respondent shall ensure that
a plan for supervision of Respondent's duties is submitted to ORI
for approval; the supervision plan must be designed to ensure the
scientific integrity of Respondent's research contribution;
Respondent agrees that he will not participate in any PHS-supported
research until such a supervision plan is submitted to and approved
by ORI; Respondent agrees to maintain responsibility for compliance
with the agreed upon supervision plan;
(2) that any institution employing him must submit, in
conjunction with each application for PHS funds, or report,
manuscript, or abstract involving PHS-supported research in which
Respondent is involved, a certification to ORI that the data
provided by Respondent are based on actual experiments or are
otherwise legitimately derived and that the data, procedures, and
methodology are accurately reported in the application, report,
manuscript, or abstract; and
(3) to exclude himself voluntarily from serving in any advisory
capacity to PHS including, but not limited to, service on any PHS
advisory committee, board, and/or peer review committee, or as a
consultant.
FOR FURTHER INFORMATION CONTACT: Acting Director, Office of Research
Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240)
453-8200.
Donald Wright,
Acting Director, Office of Research Integrity.
[FR Doc. 2015-13054 Filed 5-29-15; 8:45 am]
BILLING CODE 4150-31-P
